Nanjing Pharmaceutical Group Company Limited (SHA:600713)
5.24
+0.06 (1.16%)
Sep 14, 2026, 3:00 PM CST
| Market Cap | 6.78B +3.3% |
| Revenue (ttm) | 54.82B +0.7% |
| Net Income | 628.03M +14.1% |
| EPS | 0.43 +6.6% |
| Shares Out | 1.31B |
| PE Ratio | 12.16 |
| Forward PE | n/a |
| Dividend | 0.17 (3.28%) |
| Ex-Dividend Date | Sep 17, 2026 |
| Volume | 7,978,795 |
| Open | 5.18 |
| Previous Close | 5.18 |
| Day's Range | 5.15 - 5.26 |
| 52-Week Range | 4.81 - 6.65 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 29, 2026 |